Making the most of what you've got: optimizing residual OXPHOS function in mitochondrial diseases
- PMID: 20049740
- PMCID: PMC3378150
- DOI: 10.1002/emmm.200900049
Making the most of what you've got: optimizing residual OXPHOS function in mitochondrial diseases
Abstract
Patients affected by mitochondrial OXPHOS disorders are still faced with a grim lack of therapeutic options. In this Closeup, Carlos Moraes revisits the recent data by Giovanni Manfredi on PKA's functions in the mitochondria and now its modulation can improve respiration and ATP production in COX-defective cells.
Figures
Comment on
-
Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects.EMBO Mol Med. 2009 Nov;1(8-9):392-406. doi: 10.1002/emmm.200900046. EMBO Mol Med. 2009. PMID: 20049744 Free PMC article.
References
-
- Acin-Perez, et al. 2009a. Modulation of mitochondrial protein phosphorylation by soluble aclenylyl cylase ameliorates cytochrome oxidase defects. EMBO Mol Med 1: 392–406.
-
- Bastin J, Aubey F, Rotig A, Munnich A, Djouadi F. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J Clin Endocrinol Metab. 2008;93:1433–1441. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
